Woodley Farra Manion Portfolio Management Inc Eagle Pharmaceuticals, Inc. Transaction History

Woodley Farra Manion Portfolio Management Inc

  • $1.83 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020
SELL
$34.37 - $60.07 $10,311 - $18,021
-300 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$54.32 - $64.31 $16,296 - $19,293
300 New
300 $18,000

Others Institutions Holding EGRX

# of Institutions
78
Shares Held
9.89M
Call Options Held
1.01M
Put Options Held
0
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Woodley Farra Manion Portfolio Management Inc Portfolio

Follow Woodley Farra Manion Portfolio Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email